Nephrology & Kidney Care

Why it matters

Kidney disease is often silent until late, and its risks are tightly linked to hypertension, diabetes, pregnancy, infection, and medication safety. KDIGO and WHO PEN guidance emphasize staging, risk review, renal-aware prescribing, blood-pressure and glycemic control, and timely referral.

InBasket AI keeps this care-domain pathway connected to one continuous patient record so a small care team can work from a single, trustworthy source of truth — part of expanding access to care for the next billion people.

Designed with reference to recognized global, national, and clinical standards

This care area is designed with reference to a standards ecosystem, including global guidance, national protocols, specialty-society recommendations, interoperability standards, and programme reporting requirements where applicable:

• KDIGO chronic kidney disease staging and risk guidance
• WHO Package of Essential Noncommunicable (PEN) disease interventions
• WHO HEARTS / hypertension guidance
• WHO medication safety guidance for renal-risk prescribing
• National Ministry of Health standard treatment guidelines, essential medicines lists, and local scope-of-practice rules for the implementation setting
• HL7 FHIR, ICD-10, LOINC, SNOMED CT, and local terminology/coding standards where adopted

Standards sources

These sources substantiate the standards named above. Implementation-specific national protocols are selected from official national or regional authorities during deployment.

1. [1]KDIGO guidelines
2. [2]World Health Organization guidelines and publications
3. [3]Official national Ministry of Health protocols for the implementation setting — Implementation-specific: selected from the official national or regional authority during deployment.
4. [4]HL7 FHIR
5. [5]WHO ICD classifications
6. [6]LOINC
7. [7]SNOMED CT

Evidence sources

• KDIGO CKD guideline